Literature DB >> 16223882

WWOX gene restoration prevents lung cancer growth in vitro and in vivo.

Muller Fabbri1, Dimitrios Iliopoulos, Francesco Trapasso, Rami I Aqeilan, Amelia Cimmino, Nicola Zanesi, Sai Yendamuri, Shuang-Yin Han, Dino Amadori, Kay Huebner, Carlo M Croce.   

Abstract

The WWOX (WW domain containing oxidoreductase) gene at the common fragile site, FRA16D, is altered in many types of cancer, including lung cancer. We have examined the tumor suppressor function of WWOX in preclinical lung cancer models. The WWOX gene was expressed in lung cancer cell lines through recombinant adenovirus (Ad) infection (Ad-WWOX), and through a drug [ponasterone A, (ponA)]-inducible system. After WWOX restoration in vitro, endogenous Wwox protein-negative cell lines (A549, H460, and H1299) underwent apoptosis through activation of the intrinsic apoptotic caspase cascade in A549 and H460 cells. Ectopic expression of Wwox caused dramatic suppression of tumorigenicity of A549, H460, and H1299 cells in nude mice after Ad-WWOX infection and after ponA induction of Wwox expression in H1299 lung cancer cells. Tumorigenicity and in vitro growth of U2020 (Wwox-positive) lung cancer cells was unaffected by Wwox overexpression. This study confirms that WWOX is a tumor suppressor gene and is highly effective in preventing growth of lung cancer xenografts, whether introduced through viral infection or by induction of a silent WWOX transgene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223882      PMCID: PMC1266103          DOI: 10.1073/pnas.0505485102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

Authors:  J Nemunaitis; S G Swisher; T Timmons; D Connors; M Mack; L Doerksen; D Weill; J Wait; D D Lawrence; B L Kemp; F Fossella; B S Glisson; W K Hong; F R Khuri; J M Kurie; J J Lee; J S Lee; D M Nguyen; J C Nesbitt; R Perez-Soler; K M Pisters; J B Putnam; W R Richli; D M Shin; G L Walsh; J Merritt; J Roth
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Flow cytometric methods of analyzing apoptotic cells.

Authors:  A E Milner; J M Levens; C D Gregory
Journal:  Methods Mol Biol       Date:  1998

3.  Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.

Authors:  J A Roth; S G Swisher; J A Merritt; D D Lawrence; B L Kemp; C H Carrasco; A K El-Naggar; F V Fossella; B S Glisson; W K Hong; F R Khurl; J M Kurie; J C Nesbitt; K Pisters; J B Putnam; D S Schrump; D M Shin; G L Walsh
Journal:  Semin Oncol       Date:  1998-06       Impact factor: 4.929

4.  Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.

Authors:  J A Roth; D Nguyen; D D Lawrence; B L Kemp; C H Carrasco; D Z Ferson; W K Hong; R Komaki; J J Lee; J C Nesbitt; K M Pisters; J B Putnam; R Schea; D M Shin; G L Walsh; M M Dolormente; C I Han; F D Martin; N Yen; K Xu; L C Stephens; T J McDonnell; T Mukhopadhyay; D Cai
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

5.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.

Authors:  S G Swisher; J A Roth; J Nemunaitis; D D Lawrence; B L Kemp; C H Carrasco; D G Connors; A K El-Naggar; F Fossella; B S Glisson; W K Hong; F R Khuri; J M Kurie; J J Lee; J S Lee; M Mack; J A Merritt; D M Nguyen; J C Nesbitt; R Perez-Soler; K M Pisters; J B Putnam; W R Richli; M Savin; D S Schrump; D M Shin; A Shulkin; G L Walsh; J Wait; D Weill; M K Waugh
Journal:  J Natl Cancer Inst       Date:  1999-05-05       Impact factor: 13.506

7.  Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection.

Authors:  D Weill; M Mack; J Roth; S Swisher; S Proksch; J Merritt; J Nemunaitis
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

8.  Loss of FHIT function in lung cancer and preinvasive bronchial lesions.

Authors:  G Sozzi; U Pastorino; L Moiraghi; E Tagliabue; F Pezzella; C Ghirelli; S Tornielli; L Sard; K Huebner; M A Pierotti; C M Croce; S Pilotti
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

9.  Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.

Authors:  Masahiko Nishizaki; Ji-Ichiro Sasaki; Bingliang Fang; Edward N Atkinson; John D Minna; Jack A Roth; Lin Ji
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

10.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Authors:  M Ohta; H Inoue; M G Cotticelli; K Kastury; R Baffa; J Palazzo; Z Siprashvili; M Mori; P McCue; T Druck; C M Croce; K Huebner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

View more
  53 in total

1.  Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.

Authors:  Kyle C Kurek; Sara Del Mare; Zaidoun Salah; Suhaib Abdeen; Hussain Sadiq; Suk-Hee Lee; Eugenio Gaudio; Nicola Zanesi; Kevin B Jones; Barry DeYoung; Gail Amir; Mark Gebhardt; Matthew Warman; Gary S Stein; Janet L Stein; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.

Authors:  Dan He; Yi-wang Zhang; Na-na Zhang; Lu Zhou; Jian-ning Chen; Ye Jiang; Chun-kui Shao
Journal:  Med Oncol       Date:  2015-02-27       Impact factor: 3.064

3.  A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24.

Authors:  Kathryn S Higginbotham; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Peggy A Schuyler; W Dale Plummer; Marcia E Freudenthal; Amy Trentham-Dietz; Polly A Newcomb; Fritz F Parl; Melinda E Sanders; David L Page; Kathleen M Egan; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-07-17       Impact factor: 4.254

Review 4.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

5.  Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours.

Authors:  D Ramos; M Abba; J A López-Guerrero; J Rubio; E Solsona; S Almenar; A Llombart-Bosch; C M Aldaz
Journal:  Histopathology       Date:  2008-04-29       Impact factor: 5.087

Review 6.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

7.  Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.

Authors:  Hee Yi; Hee-Jung Cho; Soo-Min Cho; Dong-Goo Lee; A M Abd El-Aty; So-Jeong Yoon; Gun-Won Bae; Kwang Nho; Bokyung Kim; Chi-Ho Lee; Jin-Suk Kim; Michael G Bartlett; Ho-Chul Shin
Journal:  BMC Cancer       Date:  2010-05-18       Impact factor: 4.430

8.  Oncosuppressor proteins of fragile sites are reduced in cervical cancer.

Authors:  Enrico Giarnieri; Nicola Zanesi; Arianna Bottoni; Mauro Alderisio; Ankica Lukic; Aldo Vecchione; Vincenzo Ziparo; Carlo Maria Croce; Rita Mancini
Journal:  Cancer Lett       Date:  2009-08-22       Impact factor: 8.679

9.  Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats.

Authors:  Meng-Yen Li; Feng-Jie Lai; Li-Jin Hsu; Chen-Peng Lo; Ching-Li Cheng; Sing-Ru Lin; Ming-Hui Lee; Jean-Yun Chang; Dudekula Subhan; Ming-Shu Tsai; Chun-I Sze; Subbiah Pugazhenthi; Nan-Shan Chang; Shur-Tzu Chen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

10.  Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Jan Parker-Thornburg; Donna F Kusewitt; Mark T Bedford; C Marcelo Aldaz
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.